Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
         
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Too Soon to Be Concerned About HIV Drug Resistance? (Editor's Pick)

Aug 30, 2015

I was diagnosed positive on March 3 2015. On April 27 my VL was 472,820 and T-cell 117 and CD4% 4.5. Genome test showed no resistance. I started Stribild q.d. My 2nd lab result VL 145 and T-cell 404! 3rd Lab result VL 100 and T-cell 285. Today my result: VL 220 and Tcell 305 (CD4% decreased from 9% to 8.7%. I have been 100% compliant taking my ART drug. I'm very concerned that I'm developing resistance too early in the game. Should I worry?

Response from Dr. Holodniy

I am not concerned. You have had a fabulous response in both viral load and CD4 count. You started with a very high viral load and you are only about 3-4 months into treatment. It is very unlikely that resistance is an issue at this point, given the negative resistance test at baseline. There is no significant difference in a CD4% of 9 and 8.7% percent.



Previous
CD4 count drops from 504 to 364
Next
Reducing PCR #

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement